Public Sector Pension Investment Board decreased its position in shares of CVS Health Corporation (NYSE:CVS – Free Report) by 16.7% during the 3rd quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 394,761 shares of the pharmacy operator’s stock after selling 79,343 shares during the quarter. Public Sector Pension Investment Board’s holdings in CVS Health were worth $34,617,000 as of its most recent SEC filing.
A number of other hedge funds have also recently bought and sold shares of CVS. BlackRock Inc. bought a new position in CVS Health in the second quarter valued at about $12,747,462,000. State Street Corp increased its position in CVS Health by 26.3% in the second quarter. State Street Corp now owns 74,927,064 shares of the pharmacy operator’s stock worth $7,751,205,000 after purchasing an additional 15,604,883 shares during the period. Bank of America Corp DE raised its holdings in CVS Health by 148.0% during the 2nd quarter. Bank of America Corp DE now owns 23,188,670 shares of the pharmacy operator’s stock worth $2,398,868,000 after purchasing an additional 13,836,701 shares during the last quarter. Pzena Investment Management LLC bought a new stake in CVS Health during the 2nd quarter worth about $1,217,558,000. Finally, Wellington Management Group LLP raised its holdings in CVS Health by 49.8% during the 2nd quarter. Wellington Management Group LLP now owns 33,801,113 shares of the pharmacy operator’s stock worth $3,496,725,000 after purchasing an additional 11,233,381 shares during the last quarter. 80.66% of the stock is currently owned by institutional investors.
Insider Buying and Selling
In other news, EVP Prem Shah purchased 23,855 shares of the firm’s stock in a transaction dated Friday, November 6th. The stock was bought at an average price of $83.89 per share, with a total value of $2,001,195.95. Following the acquisition, the executive vice president directly owned 88,516 shares of the company’s stock, valued at approximately $7,425,607.24. This represents a 36.89% increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Insiders own 0.85% of the company’s stock.
CVS Health Price Performance
CVS Health stock opened at $81.33 on Thursday. The company has a current ratio of 0.85, a quick ratio of 0.66 and a debt-to-equity ratio of 0.71. The firm has a market capitalization of $104.05 billion, a P/E ratio of 9.47, a PEG ratio of 0.75 and a beta of 0.58. The business has a 50-day moving average of $89.00 and a 200-day moving average of $89.25. CVS Health Corporation has a 1 year low of $69.51 and a 1 year high of $110.68.
CVS Health (NYSE:CVS – Get Free Report) last announced its quarterly earnings results on Wednesday, November 4th. The pharmacy operator reported $2.09 earnings per share for the quarter, beating analysts’ consensus estimates of $1.65 by $0.44. The business had revenue of $108.40 billion for the quarter, compared to the consensus estimate of $104.72 billion. CVS Health had a net margin of 2.62% and a return on equity of 13.65%. CVS Health’s revenue for the quarter was up 5.4% on a year-over-year basis. During the same period last year, the company posted $1.60 EPS. On average, equities analysts anticipate that CVS Health Corporation will post 8.26 EPS for the current year.
CVS Health Announces Dividend
The company also recently announced a quarterly dividend, which was paid on Monday, November 2nd. Shareholders of record on Thursday, October 22nd were paid a $0.6650 dividend. This represents a $2.66 annualized dividend and a yield of 3.3%. The ex-dividend date of this dividend was Thursday, October 22nd. CVS Health’s dividend payout ratio is presently 30.97%.
Wall Street Analysts Forecast Growth
CVS has been the topic of several recent research reports. BMO Capital Markets set a $112.00 target price on shares of CVS Health in a research note on Wednesday, September 9th. Royal Bank Of Canada lowered their price target on shares of CVS Health from $113.00 to $108.00 and set an “outperform” rating for the company in a research report on Monday. UBS Group dropped their price target on shares of CVS Health from $118.00 to $107.00 and set a “buy” rating for the company in a research note on Thursday, November 5th. Barclays cut their price objective on shares of CVS Health from $108.00 to $107.00 and set an “overweight” rating on the stock in a report on Thursday, November 5th. Finally, Robert W. Baird set a $107.00 price objective on shares of CVS Health in a research note on Thursday, August 6th. Twenty-three equities research analysts have rated the stock with a Buy rating and two have given a Hold rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $107.33.
Check Out Our Latest Stock Report on CVS
Key Stories Impacting CVS Health
Here are a few of the latest stories about CVS:
- Positive Sentiment: A CVS study suggests GLP-1 medications could reduce overall healthcare spending if their net price is $350 or less. That could support wider use of the drugs, though the savings depend on affordability and access. CVS Health Study Says GLP-1s Save Money If Net Price Is $350 Or Lower
- Neutral Sentiment: CVS appointed Teresa Heitsenrether to its board amid a turnaround effort. The appointment may add relevant leadership experience, but the article does not identify a near-term financial impact. CVS Health adds Teresa Heitsenrether to its board amid turnaround push
- Negative Sentiment: Coverage also flagged the risk that higher medical costs could pressure CVS’s earnings, while RBC issued a pessimistic stock-price forecast. The lack of a dividend increase may further disappoint income-focused investors. How Bad Would Higher Medical Costs Be For CVS Health Stock? Royal Bank of Canada Issues Pessimistic Forecast for CVS Health Stock Price
CVS Health Profile
CVS Health is a U.S.-based health care company that operates retail pharmacies, provides pharmacy benefit management services, and offers health insurance and other health services. Its businesses include CVS Pharmacy, pharmacy benefit manager CVS Caremark, and Aetna, its health benefits division. The company also provides care through MinuteClinic walk-in clinics and health care businesses including Oak Street Health and Signify Health. Its services span prescription fulfillment, pharmacy benefit management, health insurance, primary care, and in-home and community-based care.
Featured Stories
- Five stocks we like better than CVS Health
- Amazon’s Zoox Just Joined Uber—Could That Change the Robotaxi Threat?
- Drilling for Yield in the Gulf: Chevron Drops Anchor in Deepwater
- TJX Stock Flashes a Strong Bullish Signal as Its $3 Billion Buyback Plan Takes Shape
- Viking’s Low-Water Miss Looks Like a Buy-the-Dip Opportunity
Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.
